The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Leinco Technologies sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Leinco Technologies is a biotechnology company that manufactures early discovery research products including recombinant proteins, ELISA kits, antibodies, second-step reagents and other life sciences products. It provides edge products and services for protein therapeutics, life science research and diagnostics. The company’s product portfolio includes antibodies for flow cytometry, monoclonal antibodies (in vivo and in vitro grade), polyclonal antibodies, SARS-CoV-2 antibodies and proteins, growth factors and cytokines, and others. It also offers custom services such as IVD antibodies and protein production services, immunoassay development services, monoclonal antibody manufacturing, conjugation, and purification services. The company has a presence in Australia, Belgium, France, Germany, Italy, Ireland, Japan, Malaysia, Thailand, and other countries. Leinco Technologies is headquartered in St. Louis, Missouri, the US.
The key metrics of Leinco Technologies related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Leinco Technologies is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Leinco Technologies.
For a detailed understanding of the performance of Leinco Technologies, buy the report here.